Summary
The kinetics of the aminothiazolyliminomethoxy cephalosporin, cefmenoxime, were determined after a 30 min intravenous infusion of 15 mg/kg body weight in 6 adult subjects undergoing continuous ambulatory peritoneal dialysis. Concentrations of cefmenoxime in serum, urine and dialysate were determined by high-pressure liquid chromatography. The mean peak serum concentration was 92.8±11.6 µg/ml and the harmonic mean for the elimination half-life was 5.46 h. The volume of distribution at steady-state was 14.60±3.01 l/kg. Total body clearance of the drug was 31±7.7 ml/min with 8±5% and 5.75±2.72% of the administered dose being eliminated by renal and peritoneal clearance, respectively. Peritoneal clearance for all exchanges (n=24) was 1.93±68 ml/min. These data suggest that peritoneal losses of this drug are minimal and doses conventionally employed in advanced renal failure can be utilized in the management of systemic infections.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kondom NY, Tsuchiya K (1981) Binding of cefmenoxime (SCE-1365) to serum proteins. Chemotherapy 24: 200–205
Reitberg DP, Cumbo TJ, Smith IL, Schentag JJ (1984) Effect of protein binding on cefmenoxime steady-state kinetics in critical patients. Clin Pharmacol Ther 35: 64–73
Granneman GR, Sennelo LT, Steinberg FJ, Sanders RC (1982) Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects. Antimicrob Agents Chemother 21: 141–145
Sennello LT, Quinn D, Rollins DE, Tolman KG, Sonders RC (1983) Effect of probenecid on the pharmacokinetics of cefmenoxime. Antimicrob Agents Chemother 23: 803–807
Gambertoglio JF, Alexander DP, Barriere SL (1984) Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis. Antimicrob Agents Chemother 26: 845–849
Noonan IA, Gambertoglio JG, Barriere SL, Conte JE, Lin ET (1983) High-performance liquid chromatographic determination of cefmenoxime (AB-50912) in human plasma and urine. J Chromatogr 273: 458–463
Metzler C, Elfring G, McEwen A (1974) A package of computer programs for pharmacokinetic modeling. Biometrics 130: 562–563
Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2: 123–148
Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York
Benet LZ, Galeazzi RL (1979) Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 68: 1071–1074
Lee CS, Brater DS, Gambertoglio JF, Benet LZ (1984) Disposition kinetics of ethambutol in man. J Pharmacokinet Biopharm 8: 355–360
Polk RE, Sica DA, Kerkering TM, Kline BJ, Patterson PM, Baggett JW (1984) Cefmenoxime pharmacokinetics in patients with renal insufficiency. Antimicrob Agents Chemother 26: 322–327
Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FD (1983) Tobramycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 34: 110–116
Somani P, Shapiro R, Stockard R, Higgins (1982) Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 32: 113–121
Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC (1983) Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 33: 66–72
McIntosh ME, Smith WG, Junor BJ, Forrest G, Brodie MJ (1985) Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis. Eur J Clin Pharmacol 28: 187–191
Harford AM, Sica DA, Jartaglione T, Polk RE, Dalton HP, Poynor WJ (1986) (Nephron) Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis with peritonitis. Nephron 43: 217–222
Rogge MC, Johnson CA, Zimmerman SW, Welling PG (1985) Vancomycin disposition during continuous ambulatory peritoneal dialysis: A pharmacokinetic analysis of peritoneal drug transport. Antimicrob Agents Chemother 27: 578–582
Vas SI (1983) Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 23: 83–92
Stamm JM (1984) Cefmenoxime: In vitro activity. Am J Med 11 (6A): 1–3
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sica, D.A., Polk, R.E., Kerkering, T.M. et al. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis. Eur J Clin Pharmacol 30, 713–717 (1986). https://doi.org/10.1007/BF00608221
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00608221